Significantly higher values of HE4 were found at the time of ovarian cancer diagnosis in the group of patients who later recurred from the neoplastic process (648.1 vs. 295.5 pmol/L, p = 0.015). This evidence concerns the gene WFDC2 and ovarian carcinoma.